TY - JOUR
T1 - BEST
T2 - a web application for comprehensive biomarker exploration on large-scale data in solid tumors
AU - Liu, Zaoqu
AU - Liu, Long
AU - Weng, Siyuan
AU - Xu, Hui
AU - Xing, Zhe
AU - Ren, Yuqing
AU - Ge, Xiaoyong
AU - Wang, Libo
AU - Guo, Chunguang
AU - Li, Lifeng
AU - Cheng, Quan
AU - Luo, Peng
AU - Zhang, Jian
AU - Han, Xinwei
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Data mining from RNA-seq or microarray data has become an essential part of cancer biomarker exploration. Certain existing web servers are valuable and broadly utilized, but the meta-analysis of multiple datasets is absent. Most web servers only contain tumor samples from the TCGA database with only one cohort for each cancer type, which also means that the analysis results mainly derived from a single cohort are thin and unstable. Indeed, consistent performance across multiple independent cohorts is the foundation for an excellent biomarker. Moreover, the deeper exploration of specific biomarkers on underlying mechanisms, tumor microenvironment, and drug indications are missing in existing tools. Thus, we introduce BEST (Biomarker Exploration for Solid Tumors), a web application for comprehensive biomarker exploration on large-scale data in solid tumors. To ensure the comparability of genes between different sequencing technologies and the legibility of clinical traits, we re-annotated transcriptome data and unified the nomenclature of clinical traits. BEST delivers fast and customizable functions, including clinical association, survival analysis, enrichment analysis, cell infiltration, immunomodulator, immunotherapy, candidate agents, and genomic alteration. Together, our web server provides multiple cleaned-up independent datasets and diverse analysis functionalities, helping unleash the value of current data resources. It is freely available at https://rookieutopia.com/ .
AB - Data mining from RNA-seq or microarray data has become an essential part of cancer biomarker exploration. Certain existing web servers are valuable and broadly utilized, but the meta-analysis of multiple datasets is absent. Most web servers only contain tumor samples from the TCGA database with only one cohort for each cancer type, which also means that the analysis results mainly derived from a single cohort are thin and unstable. Indeed, consistent performance across multiple independent cohorts is the foundation for an excellent biomarker. Moreover, the deeper exploration of specific biomarkers on underlying mechanisms, tumor microenvironment, and drug indications are missing in existing tools. Thus, we introduce BEST (Biomarker Exploration for Solid Tumors), a web application for comprehensive biomarker exploration on large-scale data in solid tumors. To ensure the comparability of genes between different sequencing technologies and the legibility of clinical traits, we re-annotated transcriptome data and unified the nomenclature of clinical traits. BEST delivers fast and customizable functions, including clinical association, survival analysis, enrichment analysis, cell infiltration, immunomodulator, immunotherapy, candidate agents, and genomic alteration. Together, our web server provides multiple cleaned-up independent datasets and diverse analysis functionalities, helping unleash the value of current data resources. It is freely available at https://rookieutopia.com/ .
KW - Biomarker
KW - Immunotherapy
KW - Pancancer
KW - Shiny
KW - Survival
KW - Web server
UR - http://www.scopus.com/inward/record.url?scp=85175694935&partnerID=8YFLogxK
U2 - 10.1186/s40537-023-00844-y
DO - 10.1186/s40537-023-00844-y
M3 - Article
AN - SCOPUS:85175694935
SN - 2196-1115
VL - 10
JO - Journal of Big Data
JF - Journal of Big Data
IS - 1
M1 - 165
ER -